rs3816531

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_015175.3(NBEAL2):​c.6919+9T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0322 in 1,613,270 control chromosomes in the GnomAD database, including 2,438 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.050 ( 357 hom., cov: 33)
Exomes 𝑓: 0.030 ( 2081 hom. )

Consequence

NBEAL2
NM_015175.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -2.31

Publications

6 publications found
Variant links:
Genes affected
NBEAL2 (HGNC:31928): (neurobeachin like 2) The protein encoded by this gene contains a beige and Chediak-Higashi (BEACH) domain and multiple WD40 domains, and may play a role in megakaryocyte alpha-granule biogenesis. Mutations in this gene are a cause of gray platelet syndrome. [provided by RefSeq, Dec 2011]
NBEAL2 Gene-Disease associations (from GenCC):
  • gray platelet syndrome
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 3-47006072-T-C is Benign according to our data. Variant chr3-47006072-T-C is described in ClinVar as Benign. ClinVar VariationId is 260591.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.124 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NBEAL2NM_015175.3 linkc.6919+9T>C intron_variant Intron 43 of 53 ENST00000450053.8 NP_055990.1 Q6ZNJ1-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NBEAL2ENST00000450053.8 linkc.6919+9T>C intron_variant Intron 43 of 53 2 NM_015175.3 ENSP00000415034.2 Q6ZNJ1-1

Frequencies

GnomAD3 genomes
AF:
0.0500
AC:
7612
AN:
152150
Hom.:
353
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0760
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.123
Gnomad ASJ
AF:
0.0649
Gnomad EAS
AF:
0.131
Gnomad SAS
AF:
0.0506
Gnomad FIN
AF:
0.0145
Gnomad MID
AF:
0.0506
Gnomad NFE
AF:
0.0173
Gnomad OTH
AF:
0.0435
GnomAD2 exomes
AF:
0.0663
AC:
16481
AN:
248612
AF XY:
0.0575
show subpopulations
Gnomad AFR exome
AF:
0.0786
Gnomad AMR exome
AF:
0.231
Gnomad ASJ exome
AF:
0.0653
Gnomad EAS exome
AF:
0.137
Gnomad FIN exome
AF:
0.0170
Gnomad NFE exome
AF:
0.0194
Gnomad OTH exome
AF:
0.0471
GnomAD4 exome
AF:
0.0304
AC:
44346
AN:
1461002
Hom.:
2081
Cov.:
34
AF XY:
0.0297
AC XY:
21583
AN XY:
726742
show subpopulations
African (AFR)
AF:
0.0767
AC:
2567
AN:
33468
American (AMR)
AF:
0.217
AC:
9700
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.0661
AC:
1727
AN:
26126
East Asian (EAS)
AF:
0.143
AC:
5695
AN:
39690
South Asian (SAS)
AF:
0.0421
AC:
3632
AN:
86248
European-Finnish (FIN)
AF:
0.0182
AC:
968
AN:
53118
Middle Eastern (MID)
AF:
0.0428
AC:
247
AN:
5768
European-Non Finnish (NFE)
AF:
0.0160
AC:
17754
AN:
1111524
Other (OTH)
AF:
0.0341
AC:
2056
AN:
60350
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
2581
5162
7743
10324
12905
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
922
1844
2766
3688
4610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0501
AC:
7633
AN:
152268
Hom.:
357
Cov.:
33
AF XY:
0.0519
AC XY:
3861
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.0761
AC:
3164
AN:
41552
American (AMR)
AF:
0.123
AC:
1876
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0649
AC:
225
AN:
3468
East Asian (EAS)
AF:
0.132
AC:
683
AN:
5184
South Asian (SAS)
AF:
0.0506
AC:
244
AN:
4822
European-Finnish (FIN)
AF:
0.0145
AC:
154
AN:
10608
Middle Eastern (MID)
AF:
0.0510
AC:
15
AN:
294
European-Non Finnish (NFE)
AF:
0.0173
AC:
1178
AN:
68010
Other (OTH)
AF:
0.0435
AC:
92
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
358
716
1073
1431
1789
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
84
168
252
336
420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0382
Hom.:
97
Bravo
AF:
0.0622
Asia WGS
AF:
0.0650
AC:
225
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 04, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Gray platelet syndrome Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.69
CADD
Benign
0.13
DANN
Benign
0.73
PhyloP100
-2.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3816531; hg19: chr3-47047562; COSMIC: COSV52757124; COSMIC: COSV52757124; API